{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:56:21Z","timestamp":1763441781625,"version":"3.45.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan","award":["23KC2002"],"award-info":[{"award-number":["23KC2002"]}]},{"name":"Research Program from the Japan Agency for Medical Research and Development","award":["JP19mk0101086h0003"],"award-info":[{"award-number":["JP19mk0101086h0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10620-025-09197-3","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:24:13Z","timestamp":1752139453000},"page":"3857-3862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Maternal Mosapride Citrate Hydrate Exposure During the First Trimester: Assessing Risks for Congenital Anomalies"],"prefix":"10.1007","volume":"70","author":[{"given":"Yumiko","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1106-871X","authenticated-orcid":false,"given":"Hisashi","family":"Tagashira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0018-8210","authenticated-orcid":false,"given":"Yuki","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-9275","authenticated-orcid":false,"given":"Mikako","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-7172","authenticated-orcid":false,"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"9197_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14709","author":"K Hishinuma","year":"2021","unstructured":"Hishinuma K, Yamane R, Yokoo I. Pregnancy outcome after first trimester exposure to domperidone\u2014an observational cohort study. Journal of Obstetrics. 2021. https:\/\/doi.org\/10.1111\/jog.14709.","journal-title":"Journal of Obstetrics"},{"key":"9197_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/cga.12471","author":"S Hatakeyama","year":"2022","unstructured":"Hatakeyama S, Goto M, Yamamoto A et al. The safety of pranlukast and montelukast during the first trimester of pregnancy: a prospective, two-centered cohort study in Japan. Congenit Anom. 2022. https:\/\/doi.org\/10.1111\/cga.12471.","journal-title":"Congenit Anom."},{"key":"9197_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/cga.12577","author":"M Goto","year":"2024","unstructured":"Goto M, Anzai T, Yamane R, Yakuwa N, Takahashi K, Murashima A. Pregnancy outcomes after first-trimester exposure to fluoroquinolones: findings based on an integrated database from two Japanese institutions. Congenit Anom. 2024. https:\/\/doi.org\/10.1111\/cga.12577.","journal-title":"Congenit Anom"},{"key":"9197_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40780-024-00393-3","volume":"10","author":"A Nishimura","year":"2024","unstructured":"Nishimura A, Furugen A, Kobayashi M, Takekuma Y, Yakuwa N, Goto M et al. Effects of famotidine use during pregnancy: an observational cohort study. J Pharm Health Care Sci. 2024;10:70.","journal-title":"J Pharm Health Care Sci."},{"key":"9197_CR5","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1248\/bpb.b24-00080","volume":"47","author":"Y Miki","year":"2024","unstructured":"Miki Y, Koga Y, Taogoshi T et al. Assessment of the safety of exposure to Cefcapene Pivoxil during the first trimester of pregnancy: a prospective cohort study in Japan. Biol Pharm Bull. 2024;47:1301\u20131306.","journal-title":"Biol Pharm Bull."},{"key":"9197_CR6","doi-asserted-by":"crossref","unstructured":"Honma M, Suzuki N, Goto M, Obara T, Saito Y, Nakajima K, et al. A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan. Congenit Anom (Kyoto) [Internet]. 2025 Jan [cited 2024 Dec 3];65(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39617399\/","DOI":"10.1111\/cga.12588"},{"key":"9197_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cga.12557","author":"M Usuda","year":"2024","unstructured":"Usuda M, Jwa SC, Goto M et al. Risk of major birth defects after first-trimester exposure to carbocisteine and ambroxol: a multicenter prospective cohort study using counseling data for drug safety during pregnancy. Congenit Anom. 2024. https:\/\/doi.org\/10.1111\/cga.12557.","journal-title":"Congenit Anom."},{"key":"9197_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1254\/fpj.113.299","volume":"113","author":"N Yoshida","year":"1999","unstructured":"Yoshida N. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Nihon Yakurigaku Zasshi. 1999;113:299\u2013307.","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"9197_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5056\/jnm20061","volume":"27","author":"JH Park","year":"2021","unstructured":"Park JH, Lee KN, Lee OY et al. Efficacy and safety of DWJ1252 compared with Gasmotin in the treatment of functional dyspepsia: a multicenter, randomized, double-blind, active-controlled study. J Neurogastroenterol Motil. 2021;27:87\u201396.","journal-title":"J Neurogastroenterol Motil."},{"key":"9197_CR10","unstructured":"Package insert for mosapride [Internet]. [cited 2024 Dec 18]. Available from: https:\/\/www.info.pmda.go.jp\/go\/pack\/2399010B1034_1_12\/"},{"key":"9197_CR11","first-page":"3469","volume":"21","author":"H Nakamura","year":"1993","unstructured":"Nakamura H, Takiue H, Funabashi H, Terada Y. Mosapride Citrate\u306e\u751f\u6b96\u30fb\u767a\u751f\u6bd2\u6027\u8a66\u9a13(\u7b2c4\u5831)-\u30a6\u30b5\u30ae\u306b\u304a\u3051\u308b\u80ce\u5150\u306e\u5668\u5b98\u5f62\u6210\u671f\u6295\u4e0e\u8a66\u9a13- [Reproductive and developmental toxicity study of mosapride citrate (Part 4): administration during the organogenesis period in rabbits]. Pharmacology & Therapeutics. 1993;21:3469\u20133479.","journal-title":"Pharmacology & Therapeutics."},{"key":"9197_CR12","unstructured":"{Nakamura, H. , Sugisawa, K. , Funabashi, H. , & Terada, Y. Mosapride Citrate\u306e\u751f\u6b96\u30fb\u767a\u751f\u6bd2\u6027\u8a66\u9a13(\u7b2c3\u5831)\u2015\u30e9\u30c3\u30c8\u306b\u304a\u3051\u308b\u5468\u7523\u671f\u304a\u3088\u3073\u6388\u4e73\u671f\u6295\u4e0e\u8a66\u9a13\u2015 [Reproductive and developmental toxicity study of mosapride citrate (Part 3): Administration during the perinatal and lactation periods in rats].}. Pharmacology & Therapeutics. 1993;21(10):3447\u201368."},{"key":"9197_CR13","first-page":"3423","volume":"21","author":"K Shigematsu","year":"1993","unstructured":"Shigematsu K, Nakamura H, Funabashi H, Nishimura K. Mosapride Citrate\u306e\u751f\u6b96\u30fb\u767a\u751f\u6bd2\u6027\u8a66\u9a13(\u7b2c2\u5831)-\u30e9\u30c3\u30c8\u306b\u304a\u3051\u308b\u80ce\u5150\u306e\u5668\u5b98\u5f62\u6210\u671f\u6295\u4e0e\u8a66\u9a13-[Reproductive and developmental toxicity study of mosapride citrate (Part 2): Administration during the fetal organogenesis period in rats]. Pharmacology & Therapeutics. 1993;21:3423\u20133445.","journal-title":"Pharmacology & Therapeutics."},{"key":"9197_CR14","first-page":"3411","volume":"21","author":"H Nakamura","year":"1993","unstructured":"Nakamura H, Ikeya M, Funabashi H, Terada Y. Mosapride Citrate\u306e\u751f\u6b96\u30fb\u767a\u751f\u6bd2\u6027\u8a66\u9a13(\u7b2c1\u5831)-\u30e9\u30c3\u30c8\u306b\u304a\u3051\u308b\u598a\u5a20\u524d\u304a\u3088\u3073\u598a\u5a20\u521d\u671f\u6295\u4e0e\u8a66\u9a13-[Reproductive and developmental toxicity study of mosapride citrate (Part 1): Pre- and early pregnancy administration in rats]. Pharmacology & Therapeutics. 1993;21:3411\u20133422.","journal-title":"Pharmacology & Therapeutics."},{"key":"9197_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbr\u00fcck F, Wacker E, Allignol A, Weber-Schoendorfer C et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33:453\u2013462.","journal-title":"J Clin Psychopharmacol."},{"key":"9197_CR16","unstructured":"EUROCAT Guide 1.4 and Reference Documents (Last update version 15\/11\/2019) [Internet]. Available from: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/sites\/default\/files\/JRC-EUROCAT-Full-Guide-1.4-version- 15-Nov-2019.pdf"},{"key":"9197_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/jama.2013.278343","volume":"310","author":"B Pasternak","year":"2013","unstructured":"Pasternak B, Svanstr\u00f6m H, M\u00f8lgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA. 2013;310:1601\u20131611.","journal-title":"JAMA."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:53:48Z","timestamp":1763441628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9197"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09197-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}